Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,380,365
  • Shares Outstanding, K 157,217
  • Annual Sales, $ 58,440 K
  • Annual Income, $ -80,740 K
  • EBIT $ -141 M
  • EBITDA $ -138 M
  • 60-Month Beta 1.26
  • Price/Sales 24.00
  • Price/Cash Flow N/A
  • Price/Book 3.95

Options Overview Details

View History
  • Implied Volatility 71.61% ( +8.04%)
  • Historical Volatility 63.67%
  • IV Percentile 10%
  • IV Rank 17.10%
  • IV High 252.21% on 06/12/24
  • IV Low 34.35% on 06/11/24
  • Put/Call Vol Ratio 0.19
  • Today's Volume 96
  • Volume Avg (30-Day) 350
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 17,791
  • Open Int (30-Day) 17,922

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.23
  • Number of Estimates 6
  • High Estimate -0.14
  • Low Estimate -0.28
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +17.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.21 +4.45%
on 11/21/24
11.77 -27.18%
on 10/28/24
-2.80 (-24.58%)
since 10/21/24
3-Month
8.11 +5.67%
on 09/10/24
11.77 -27.18%
on 10/28/24
-0.65 (-7.10%)
since 08/21/24
52-Week
2.14 +299.77%
on 11/27/23
11.77 -27.18%
on 10/28/24
+6.38 (+291.55%)
since 11/21/23

Most Recent Stories

More News
Ocular Therapeutix: Q3 Earnings Snapshot

Ocular Therapeutix: Q3 Earnings Snapshot

OCUL : 8.56 (-2.51%)
Ocular Therapeutixâ„¢ Reports Third Quarter 2024 Results and Business Highlights

OCUL : 8.56 (-2.51%)
Ocular Therapeutixâ„¢ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV

OCUL : 8.56 (-2.51%)
Ocular Therapeutixâ„¢ Appoints Namrata Saroj, OD, as Chief Business Officer

OCUL : 8.56 (-2.51%)
Ocular Therapeutixâ„¢ to Report Third Quarter 2024 Results on November 14, 2024

OCUL : 8.56 (-2.51%)
Ocular Therapeutixâ„¢ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLIâ„¢ in Wet AMD

OCUL : 8.56 (-2.51%)
Ocular Therapeutixâ„¢ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OCUL : 8.56 (-2.51%)
Ocular Therapeutixâ„¢ to Present at October Ophthalmology Meetings

OCUL : 8.56 (-2.51%)
Ocular Therapeutix: Q2 Earnings Snapshot

Ocular Therapeutix: Q2 Earnings Snapshot

OCUL : 8.56 (-2.51%)
3 Standout Stocks Under $10 With 86% Upside Potential or More

As the chances for a September rate cut grow even stronger, these three penny stocks can emerge as substantial wealth creators.

AMZN : 198.01 (-2.40%)
AAPL : 229.16 (+0.07%)
NVDA : 147.83 (+1.33%)
OPAL : 3.75 (+2.18%)
OCUL : 8.56 (-2.51%)
NUVB : 2.65 (+2.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular...

See More

Key Turning Points

3rd Resistance Point 9.40
2nd Resistance Point 9.19
1st Resistance Point 8.99
Last Price 8.56
1st Support Level 8.57
2nd Support Level 8.36
3rd Support Level 8.16

See More

52-Week High 11.77
Last Price 8.56
Fibonacci 61.8% 8.10
Fibonacci 50% 6.96
Fibonacci 38.2% 5.82
52-Week Low 2.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar